1. 5-Aminomethylbenzimidazoles as potent ITK antagonists.
- Author
-
Riether D, Zindell R, Kowalski JA, Cook BN, Bentzien J, Lombaert SD, Thomson D, Kugler SZ Jr, Skow D, Martin LS, Raymond EL, Khine HH, O'Shea K, Woska JR Jr, Jeanfavre D, Sellati R, Ralph KL, Ahlberg J, Labissiere G, Kashem MA, Pullen SS, and Takahashi H
- Subjects
- Animals, Benzimidazoles pharmacology, CD3 Complex biosynthesis, Drug Design, Enzyme Inhibitors pharmacology, Female, Hepatocytes metabolism, Humans, Inhibitory Concentration 50, Mice, Mice, Inbred BALB C, Rats, Rats, Sprague-Dawley, Structure-Activity Relationship, Benzimidazoles chemical synthesis, Chemistry, Pharmaceutical methods, Enzyme Inhibitors chemical synthesis, Protein-Tyrosine Kinases antagonists & inhibitors
- Abstract
Benzamide 1 demonstrated good potency as a selective ITK inhibitor, however the amide moiety was found to be hydrolytically labile in vivo, resulting in low oral exposure and the generation of mutagenic aromatic amine metabolites. Replacing the benzamide with a benzylamine linker not only addressed the toxicity issue, but also improved the cellular and functional potency as well as the drug-like properties. SAR studies around the benzylamines and the identification of 10n and 10o as excellent tools for proof-of-concept studies are described.
- Published
- 2009
- Full Text
- View/download PDF